NovoCure Ltd

+4.60 (+6.08%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.39B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$135.35 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$74.14
50-Day MA$78.50
200-Day MA$93.18
See more pivots

NovoCure Ltd Stock, NASDAQ:NVCR

No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF
Phone: +44.15.3475.6700
Number of Employees: 1167


NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.